Category: Diabetes

Posted on by

Has your doctor told you to improve your circulation? Dr. Fiott answers your questions

Doctor says improve your circulation

Practical Answers, Big Issues – Weekly 10-minute Podcast with Dr. Fiott

Listen to 10-minute podcast

D'OXYVA-free-podcast-microcirculation

Questions answered in this episode are: How soon can I see results? How can I measure my own results? What clinical evidence exists? Is it FDA approved?

Hello everyone, welcome to the podcast. This is Dr. Fiott for D’Oxyva, the industry-leading solution for improved circulation.  Last week, I talked with you about D’Oxyva and why it is such a life-changing technology for anyone who suffers from poor circulation.  As it approached FDA approval, I believe that this will be the game-changer that amputation-prone diabetics have been praying for. And, I believe that D’Oxyva is poised to help prevent – not just diabetics – but all people in poor circulatory health from getting to that point in the first place.  A lot of people have suffered from amputation in the past because they did not have a device like D’Oxyva to help them restore their circulation. 

So, today I’ll be answering some more of the common questions that the people at D’Oxyva get from physicians, clinicians, and patients alike.  This is going to be eye-opening!

Let’s start with the FAQ that is on everyone’s mind, and that is: How soon will I see results?

Before I give you a general timeline, I should remind you that all of us have different physiology and different environmental factors affecting our circulation. And, everyone have different goals as well – some people take it for general health and to improve their workouts and their sex life, whereas others take it for more critical reasons such as reducing the likelihood of amputation due to wounds.  So, each patient will have a different experience, just like with any medical treatment or intervention. And, I’ll also note that D’Oxyva STARTS working the very first time you take it.  Literally, that very first time you take D’Oxyva, you’ll be improving your circulation and preventing further health problems.

So, for noticeable, tangible results from chronic pain, the general timeline is roughly seven to 10 days…  That’s it – chronic pain reduction or elimination in just seven to 10 days with D’Oxyva. Patients with very severe dysfunction or comorbidities may be on the higher end of that spectrum or longer, whereas people whose circumstances are less dire will likely enjoy their pain relief more quickly.  For people who are not experiencing pain but who want to enjoy improved capacity for exercise, or for activities of daily living, you could notice very immediate results. In fact, we suggest that you take D’Oxyva about 30 minutes prior to exercise to improve exercise capacity and performance.

Now, this brings us to the common question, “How do I know that my circulation is improving with D’Oxyva?” Well, measuring your progress can be easily done at home.  You can simply use a pulse oximeter on your finger; if you don’t know what that is, it is just a simple little lightweight device that is non-invasive and that you’ll barely feel.  You’ll be able to see your Perfusion Index increase in about half an hour or an hour or so.  That way, you know its working!

People also ask about the clinical merit behind D’Oxyva.  There is an abundance of clinical evidence supporting D’Oxyva’s benefits, but perhaps the greatest study that I can point you to is called, “Transdermal CO2 Increases Perfusion Index in Patients with Placenta Accreta Following Temporary Abdominal Aortic Cross-Clamping”, I mentioned this in last week’s podcast.

Additionally, evidence has been coming from eighteen of the top twenty ranked U.S. universities by world-class medical scientists and doctors. There are over two dozen exceptionally positive high-profile pilot and pivotal studies including randomized, placebo-controlled, double-blind studies that have yielded a decade-long record of zero adverse event reports. There are also hundreds of thousands of radically successful applications in over three dozen countries.

Another question that the people at D’Oxyva sometimes get asked is, “Is this FDA approved?”  FDA approval is close, but it is a very lengthy process.  I spoke a bit about this in last week’s podcast, but I’ll recap by saying that D’Oxyva has been in clinical trials for over a decade and that FDA approval is expected soon.

That’s about it for this week, everyone. I hope you’ve found this podcast helpful. In closing, keep in mind that D’Oxyva is fully self-administered and self-monitored. It not only helps with restore normal function and close up ulcer wounds, but it also an amazing way to relieve chronic pain, and to improve fitness, sex drive and performance.

Visit doxyva.com now to learn more first-hand. I’ll see you next week.

Posted on by

Talk with Dr. Fiott – Practical Answers, Big Issues (10-minute podcast)

Dr Val Fiott - Do People Ignore the Science of Exercise & Nutrition?

Hello everyone, welcome to the podcast. This is Dr. Fiott for D’Oxyva, the industry-leading solution for improved circulation. The information that I’m about to provide for you in this podcast is so ground-breaking and so important that it really could save your life or that of a loved one, so I’m going to encourage you to stay for the end of this short podcast for two big reasons: First, you’re going to find out how diabetics with foot ulcers who are amputation prone, are now avoiding amputation altogether from a very short, simple 4-8 week treatment (so yes, there is an easy answer!). Second, I’m going to provide you with a coupon code for use throughout our website anytime in the next 3 days.

But first, here’s just a little about me and why I’m here talking about D’Oxyva: I’m a former Corporate Physical Health Director for a major aging services community (one of the largest in my state, in fact), where my job was to make unhealthy people healthy again. I worked heavily with Assisted Living residents, and Independent residents as well, and the population that I served had a mean age of 88 years old, so you can imagine that almost none of those residents had consistently healthy circulation: Their blood was generally unhealthy, as was the way it circulated through their bodies. Now, this was around 15 years ago, when outpatient intervention was far more limited than it is today. Back then, outside of each resident’s medications, we only really had exercise and nutrition to help improve circulation on a daily basis at their homes. As important as exercise and nutrition are, they are not without their obstacles and their limitations – especially for those with poor mobility or poor general health. I only wish that we had D’Oxyva back then, because if we had, then improving circulation for each of the residents that I served would have been far easier and more consistent of a job for me and for my staff. And, aside from making our jobs easier, each and every one of those residents would have been healthier and physically stronger, as well.

So, today, I’m going to answer some of the common questions that professionals and consumers have about D’Oxyva, because this really is a breakthrough and I think its critical that people understand exactly what this is and why D’Oxyva is such a simple and safe solution for their circulatory problems. But, before I get to those commonly-asked questions, let me provide just a bit of clarity as to the science behind D’Oxyva and why this is considered to be so safe and effective:

decade-long excellent clinical evidence, out of the 20 top-ranked U.S. universities, literally 18 of them (including virtually all Ivy League schools) are involved in pivotal trials for updated FDA approval as universal treatment for diabetic foot ulcer treatment and amputation prevention. So, digest that for a moment: 90% of the top-ranked universities have been and are currently involved in these long-term studies. And, just to recap to be sure you understand – these studies are seeking FDA approval, (that’s the Food and Drug Administration), for D’Oxyva to become the go-to solution for two kinds of people: People with diabetic foot ulcers, and we’ll talk about that in just a second; and for amputation prevention. That’s how powerful D’Oxyva is in benefiting circulation, and delivering the blood and its nutrients to the distal tissues of the body.

So, you understand – in a world where objectivity and clinical analysis for new health technology is waning, D’Oxyva is not some fly-by-night “cash-grab” from people who aren’t taking the appropriate steps. Quite the opposite, D’Oxyva is the well-studied, clinically understood solution for diabetic foot ulcer treatment, and for improving circulation for those who are facing possible amputation due to their circulatory dysfunction.

So, with all of that said, I’m going to go ahead and answer some common questions that we’ve gotten before I provide that discount code that I mentioned, for use on any order from our website.

So, a common question is how and why is D’Oxyva beneficial? I’m going to explain it this way: Your body generally prioritizes most of its circulation to the gut, leaving the peripheral parts of the body (like the toes and fingers) less circulation to go around, and therefore less delivery of oxygen and nutrients makes it to those periphery anatomical landmarks. Improving circulation in one periphery area, such as the thumb for example, will also improve circulation throughout all of the periphery areas. So, if you take D’Oxyva in the thumb, you’re improving circulation not only in that thumb, but that hand, the other hand, the toes, the feet, and truly all of the extremities. That’s where you want the circulation if you’re not already getting enough circulation to those extremities. This is a game-changer for people who are not oxygenating their distal points enough, and especially for people with wounds in those distal areas because those wounds need more circulation to heal. This is why diabetics with foot ulcers are so especially benefited by D’Oxyva – they can easily take D’Oxyva in the thumb to speed up the healing in their feet, thereby closing their wounds due to the increased blood flow and oxygenation.

People also ask, “How often do I need to take it?” Its simple: You’re not going to have to drive yourself crazy with alarms and reminders to take D’Oxyva. You just take it once or twice per day, and generally it is only needed five days per week. So, its quick, convenient, simple, and you just do it yourself right at home. It’s perfect.

If you’d like to learn more, then visit doxyva.com of course, but I’d also encourage you to conduct a simple google search and find a study called, “Transdermal CO2 Increases Perfusion Index in Patients with Placenta Accreta Following Temporary Abdominal Aortic Cross-Clamping”. That way, you can see some of the clinical data first-hand.

Now, I’m going to have that coupon code that I promised you in just a moment, but first let me provide a reminder for your health & longevity: It’s important to understand that when D’Oxyva improves your circulation, you’re turning around your entire life for the better, and that is not hyperbole. When you improve circulation, you’re likely to see the loss of excess, unhealthy body fat, making you leaner and stronger and at less risk for heart disease, cancer, Covid-19, and other diseases. You’re also likely to improve longevity – people with poor circulation just don’t tend to live as long as those with healthy circulation. And of course, when the tissues throughout your body are well-nourished from stronger circulation, you have more energy, faster healing, and a more active life. So, please don’t do yourself the disservice of thinking of circulation as just another health metric that you don’t think much about: It is critical for your happiness, and for your existence.

As promised earlier, you’re about to save some money, and I’m not talking about 10% or 15 or even 20%, I’m referring to a one-time, 30% savings on your entire health investment at doxyva.com. Just enter code DrFiott at checkout, and please keep in mind this cannot be used in conjunction with any other existing offer. Now, this a great savings, but we can only keep it open for 3 days. So, because code DrFiott expires in 3 days, be sure to visit doxyva.com right now so you don’t forget and end up missing this opportunity. Visit doxyva.com now, and be sure to visit us next week when I’ll be answering more questions and talking about result norms – how soon you can expect results, how to measure, possible side effects, and more. I’ll see you then and at doxyva.com with coupon code DrFiott.

COMMON QUESTIONS FOR THE NEXT EPISODE:

How soon can I see results? How can I measure my own results? What clinical evidence exists? Is it FDA approved? Can kids and older folks use it? What are the side effects? What quality of life benefits does it offer? Will it heal my diabetic foot ulcer? Will it reduce my blood pressure? Blood sugar?

OTHER BENEFITS WE’LL DISCUSS IN THE NEXT EPISODE:

Self-administering, self-monitoring and sharing results with doctors and general public is the best model. Pain relief is universal for chronic long-term pain, fitness, sex drive and performance for both male and female patients.

Posted on by — Leave a comment

Effects of hypertension on microcirculation

Effects of hypertension on microcirculation

Written by: Dr. Dusan, M.D.

What is the structure and role of microcirculation?

The ‘end’ of the circulation is the microcirculation of terminal vascular beds, which distributes oxygen and nutrients to the tissue, controls inflammation and healing, and exchanges fluid with the tissue.1 The microcirculation, which includes vessels ranging in size from small arteries or arterioles with diameters of less than 100–300 mm to comparable venules, is also where flow resistance and perfusion are regulated.1,2 The formation and management of flow resistance and perfusion are particularly important in the context of hypertension. Before the blood enters the capillary region of the network, the high flow resistance in the arteriolar section causes a significant fall in intravascular pressure.2

What is the MAP and what is its role?

The definition of mean arterial pressure (MAP) is the average arterial pressure throughout one cardiac cycle, systole, and diastole. MAP is influenced by cardiac output and systemic vascular resistance, each of which is influenced by several variables. MAP is pressure necessary for adequate perfusion of the organs of the body. In case MAP is low, organ perfusion will be impaired. We should aim for MAP above 65 mmHg, as this is the pressure necessary for adequate cerebral perfusion.3

Maintaining mean arterial pressure (and low capillary pressures) under different functional settings and with rising or decreasing tissue mass necessitates a fine-tuned system of microvascular flow resistance regulatory controls. 2

The role of microcirculation in the occurrence of hypertension

Hypertension can be explained as a result of a lack of control over microvascular resistance. Changes in the systemic circulation (e.g., increased cardiac output), central control mechanisms (e.g., hormonal state), and cellular reactivity in the microvessels are all possible underlying pathophysiological causes (e.g. endothelial function). Vessels, particularly microvessels, can adapt to changing environments and functional demands constantly. This includes changes in vascular smooth muscle tone as well as longer-term alterations in vessel shape and number (‘angioadaptation’).3,4

The structure and function of the microcirculation can be altered in hypertension in at least three ways. To begin with, the processes that regulate vasomotor tone may be dysfunctional, resulting in increased vasoconstriction or diminished vasodilator responses. Second, anatomic changes to the structure of individual precapillary resistance vessels, such as an increase in the wall-to-lumen ratio, may be present. Finally, alterations in the microvascular network may occur, such as a decrease in the density (rarefaction) of arterioles or capillaries within a given vascular bed. The proportional contributions of these elements are likely to differ in different vascular beds and between different types and models of hypertension.4

Remodelling of microcirculation in hypertension

Arteriolar vasoconstriction, increased media-to-lumen (M/L) ratio of small resistance arteries, and rarefaction (density reduction) of microvessels all contribute to increased peripheral resistance in hypertension. 5 The renin-angiotensin-aldosterone system, remodelling of the extracellular matrix, accelerated development of the smooth muscle cells of the media, and higher collagen and fibronectin deposition are all involved in generating structural and functional changes in the microcirculation in hypertension. 5 Although many pharmacological treatments can lower blood pressure in hypertension, their capacity to correct structural and functional alterations in microcirculation varies. ACE inhibitors have repeatedly been demonstrated to reduce microvascular alterations, although calcium antagonist results have been inconsistent, and beta-adrenoceptor blockers appear to have no impact.5

References:

  1. Pries, A.R. (2014). Perspectives: Microcirculation in hypertension and cardiovascular disease. European Heart Journal Supplements, 16(suppl A), pp.A28–A29.
  2. Levy, B.I., Ambrosio, G., Pries, A.R. and Struijker-Boudier, H.A.J. (2001). Microcirculation in Hypertension. Circulation, 104(6), pp.735–740.
  3. DeMers, D. and Wachs, D. (2019). Physiology, mean arterial pressure. [online] Nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK538226/.
  4. Tsioufis, C., Dimitriadis, K., Katsiki, N. and Tousoulis, D. (2015). Microcirculation in Hypertension: An Update on Clinical Significance and Therapy. Current Vascular Pharmacology, [online] 13(3), pp.413–417. Available at: https://pubmed.ncbi.nlm.nih.gov/25659075/ [Accessed 21 Jan. 2022].
  5. Rizzoni, D. and Agabiti-Rosei, E. (2011). Structural abnormalities of small resistance arteries in essential hypertension. Internal and Emergency Medicine, 7(3), pp.205–212.‌
Posted on by

How Does D’OXYVA Help Diabetics?

How Does D’OXYVA Help Diabetics

Diabetics with uncontrolled high blood sugar suffer from a host of debilitating symptoms. Nerve pain, swelling and stiffness in their joints, and varicose veins caused by poor blood circulation bring extreme discomfort to their daily lives. They can occur as an indirect result of the damage that a high glucose count wreaks on blood vessels[1].  

Even worse, their hyperglycemia causes weakness in their immune system, which makes healing from ulcers, wounds, and infections labored and exhausting. In some cases, wounds don’t heal at all and the diabetes patient is forced to undergo an amputation procedure.

Aside from taking the right amount of insulin to counteract high blood pressure, there are precious few treatments available that help diabetics manage their symptoms without causing detrimental side effects.

That’s why we made D’OXYVA: to significantly improve diabetes symptoms by targeting their underlying causes with gentle, ultra-purified, super-saturated transdermal CO2.

How D’OXYVA Works to Target The Underlying Cause of Diabetes

D’OXYVA is a transdermal applicator that transfers super-saturated and ultra-purified CO2, or carbon dioxide, to the human skin that has profound beneficial effects throughout the entire body. It does not use pricks or injections; the application takes place entirely at the surface of the skin without pain.

D’OXYVA helps with a wide variety of painful conditions, including many of the symptoms that diabetics experience on a daily basis. Its non-invasive design and zero side effects (during extensive testing) make it easy and comfortable to use, bringing you relief as opposed to further pain.

1.      Stiffness

Stiffness is typically a result of poor blood circulation throughout the body. It is commonly experienced in the limbs and joints, reducing flexibility and making it hard to perform even simple daily tasks, such as picking up objects or a child, typing on a computer or phone, or walking.

CO2 works as a natural vasodilator, opening up blood vessels and allowing them to flow freely throughout the body.[2] The increased flow of blood leads to an increased flow of oxygen, which revitalizes limbs and improves stiffness.

2.      Swelling

As a result of the CO2 dilating blood vessels and improving their circulation throughout the body, swelling in the extremities caused by poor blood flow goes down. This small action can significantly reduce pain and improve mobility.

3.      Varicose Veins

Varicose veins are not directly caused by diabetes, but diabetics are at a higher risk of developing them.[3] As we mentioned earlier, high amounts of glucose in the body can damage or break the lining of your blood vessels. This in turn causes circulation problems. Sometimes, a vein will become damaged and gnarled in shape. The deformed shape causes it to overfill with blood.

Varicose veins are a painful, although usually not life-threatening condition. Typically, they are treated with compression garments which help straighten out the vein. Surgery is another treatment option, but it’s expensive and doesn’t address the root cause. Veins could become varicose again after surgery, causing an endless cycle of pricey procedures to fix what is merely a surface problem.

D’OXYVA targets the underlying cause of varicose veins, which is poor blood flow and cellular oxygen-related deficiency. Chronic venous insufficiency (CVI) is a major concern for millions of people around the world. When applied properly using the D’OXYVA transdermal applicator, the several mechanisms of actions influenced by this type of CO2 infusion significantly improves blood circulation and leads to the healing of varicose veins, as well as prevention, according to years of clinical studies at prestigious research institutions.

4.      Foot Ulcers

The high blood sugar that causes diabetes can also cause nerve damage. Damaged nerves feel painful, like pins and needles stuck in the body. Poor blood circulation can also cause nerves in the bodily extremities (such as hands and feet) to stop processing any type of feeling.

For these reasons, diabetics are more likely to develop foot ulcers.[4] As a result of the nerves in their feet not functioning properly, they do not feel the sores developing there. Improper blood flow and the high amounts of glucose in the body lead to slower healing times and greater risk of infection for those ulcers.

By improving blood circulation to the feet and certain nerve activities, the effects caused by D’OXYVA’s patented CO2 solution can help prevent the development of foot ulcers and greatly facilitate the healing process for existing ones.  

5.      Wounds

Wounds, including ulcers, cuts, and lesions, heal more slowly in diabetics. This is due to damaged blood vessels, a decreased flow of nutrients flowing to the wound, and decreased immunity increasing the risk of infection.[5]

D’OXYVA helps counteract poor blood flow caused by broken vessels by dilating them and allowing blood to move more freely to wounded and inflamed parts of the body. The oxygen and other nutrients the blood carries with it to the wound help heal it faster.

How Can Diabetics Get D’OXYVA?

D’OXYVA is nearly at the finish line for becoming a common-place treatment for symptoms associated with diabetes. It is in the final stage of receiving an emergency-use authorization, or a fast-track update to the existing FDA approval. You can subscribe to our emails and follow our social media accounts to stay updated on our progress, as well as become eligible for store discounts and gift cards.

In the meantime, you can feel safe purchasing D’OXYVA directly from our online store. We’re confident in our product’s ability to relieve your diabetic symptoms, and any other physical suffering you’re experiencing as a result of poor blood circulation. It’s shown zero side effects after rigorous clinical research and testing.

Try our non-invasive, transdermal, affordable advanced health products today and let us know how it transforms your life.

[1] “The Cold Truth About Poor Circulation Leading to Diabetes.” Amputation Prevention Center. Last modified September 24, 2018. https://www.apcofamerica.com/low-blood-flow-poor-circulation-diabetes/.

[2] “The Local Effect of Carbon Dioxide on Human Blood Vessels.” ScienceDirect.com | Science, Health and Medical Journals, Full Text Articles and Books. Accessed December 15, 2021. https://www.sciencedirect.com/science/article/abs/pii/0002870360901228.

[3] Gabbey, Amber E. “Varicose Veins: Causes, Symptoms, and Diagnosis.” Healthline. Accessed December 15, 2021. https://www.healthline.com/health/varicose-veins.

[4] The Healthline Editorial Team. “Diabetic Foot Ulcers.” Healthline. Accessed December 15, 2021. https://www.healthline.com/health/diabetic-foot-pain-and-ulcers-causes-treatments.

[5] Dening, Jedha. “Diabetes and Wound Healing: Why Is It Slower?” Healthline. Accessed December 15, 2021. https://www.healthline.com/health/diabetes/diabetes-and-wound-healing#what-leads-to-slow-healing.

Posted on by — Leave a comment

After 3 exceptionally successful diabetic foot ulcer treatment pivotal trials, Circularity Healthcare is in expanded pivotal trials for updated FDA clearance with D’OXYVA®

diabetic foot ulcer treatment pivotal trials with D'OXYVA recognize poor circulation

After three exceptionally successful diabetic foot ulcer pivotal trials, Circularity Healthcare is in expanded pivotal trials for updated FDA clearance with its D’OXYVA® (deoxyhemoglobin vasodilator) noninvasive transdermal drug delivery system at 18 of the 20 top-ranked U.S. universities for becoming a universal treatment for diabetic foot ulcers (press release). The global diabetic foot ulcer (DFU) treatment market size was valued at $7.03 billion in 2019 and is projected to reach $11.05 billion by 2027, exhibiting a CAGR of 5.9% during the forecast period, according to Fortune Business Insights.

Healing of Diabetic Foot Ulcers

Healing of wounds is typically an innate mechanism. However, certain metabolic disorders such as diabetes mellitus delays typical pace of wound healing process. Diabetic foot ulcers are most commonly caused by irritated or wounded feet, nerve damage, poor circulation, and high blood sugar (hyperglycemia). Unusual swelling, redness, irritation, and stenches on one or both feet are common initial symptoms of foot ulcer.

Treatment of Diabetic Foot Ulcers

DFU treatments, usually include control of blood sugar, removal of dead tissue, wound dressings, and negative pressure therapy. Hyperbaric oxygen therapy may be beneficial but is costly and in some cases, surgery may also improve results. These ulcers are responsible for more than 80.0% of all diabetes-related lower-leg amputations and occur in around 15.0% of diabetic patients.

Cost of Diabetic Foot Ulcer Management

High cost of ulcer management has been restricting the market from realizing its utmost potential. Many developing and underdeveloped countries demonstrate a lack of healthcare facilities, subsequently limiting market growth. However, adoption of novel therapeutics, improved biologics, and continued prioritization to avoid surgeries and amputations are estimated to offset limitations affecting the growth of the market. Thus, in turn, offering significant opportunities for the market to generate revenue.

Regional Insights

North America led the market in 2017. Rising cohort of diabetic patients and adequate healthcare facilities in the region are key factors responsible for the growth of the regional market. Long R&D and approval cycles are required due to capital-intensive nature in North America, which act as a stumbling stone for the growth of the market in the region. However, rising adoption of novel biologics and wound care devices for treatment of these ulcers are contributing to the dominance of North America.

Europe held the second largest share in the market, followed by Asia Pacific. APAC will exhibit the highest CAGR during the forecast period. Increasing prevalence of diabetes and a large geriatric population base in both India and China are supporting the growth of the regional market. This can also be attributed to increased adoption and favorable legislation in developed economies such as Japan and Australia.

Key Companies & Market Share Insights

Some of the prominent companies operating in the market are ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast A/S; Smith & Nephew Plc.; B. Braun Melsungen AG; Medline Industries, Inc.; Medtronic Plc.; Organogenesis, Inc.; Molnlycke Health Care AB; and BSN Medical GMBH. The players focus on alliances, strategic planning, new treatment planning, and research activities to achieve favorable growth. Currently, Smith & Nephew, Coloplast, CovanTec, Acelity, and 3M Healthcare are leading the market, supported by strong sales of their marketed therapeutic options for the treatment of diabetic foot ulcer.

Source

Grand View Research

Posted on by — Leave a comment

Nationally-recognized health podcast, ‘Living Life with Lynda’, teams up with Circularity Healthcare and the Beach Bums

Living Life with Lynda Show & D'OXYVA

Nationally-recognized health podcast, ‘Living Life with Lynda’, teams up with Circularity Healthcare’s D’OXYVA and the Beach Bums to discuss all things healthy living and fun!

Join the podcast party!! Our new episode educates listeners on a variety of topics and empowers them to make better life choices. Learn how D’OXYVA®, and its FDA-approved non-invasive transdermal pharmaceutical product line, is involved in 18 of the top 20 U.S. universities’ clinical trials and can offer immediate results for your most stigmatic issues including spider veins and varicose veins.

D’OXYVA is also a solution for a wide host of other conditions including erectile dysfunction, athletic performance, mood, cognition, energy, appetite, sleep and more.

In a world torn by stress and chaos, wouldn’t it be nice to have some tips and resources in your toolbox of life? Presented in a humorous and relatable manner, our health gurus and life coaches will guide the way to a happier and healthier future. Members of Beach Bums Adventures love sand between their toes, salty water and cold adult beverages. But above all else, Beach Bums pride themselves on living active and healthy lifestyles. These topics are just a snapshot of the healthy and fun adventure that awaits just around the corner. You don’t want to miss the Living Life with Lynda podcast/radio show and this special series!

Stay tuned for more info to come! Register your email in the footer on doxyva.com and get exclusive offers, show dates and early access to the show.

In the meantime, visit the website of the ‘Living Life with Lynda Show’ at www.livinglifeshow.com and click on the D’OXYVA banner to learn how you can improve your life by improving your blood flow! Don’t delay! An exclusive offer is only available to be used through September 22nd, 2021, the day of the recording of the show! We look forward to hearing from you how D’OXYVA has helped you improve your health!

Posted on by — Leave a comment

“I started using D’OXYVA for my varicose veins, and here’s what happened in just four weeks”

DOxyva for pro casual athletes, spider veins

Annie, 35 and a mother to 3 kids, shared her story of how D’OXYVA took away her worries about the pain and appearance of varicose veins and gave her a major confidence boost in just 4 weeks.

“Varicose veins have long bothersome on both sides of my family, so I was not surprised when I started to get them a little early in life,” said Annie.

Annie is an active mother and athlete. She began to notice a heaviness and pain in one of her legs long before a single varicose vein began to show up on the back of her thigh and slowly spread down her leg.

“I have always lived a healthy and active lifestyle, running and swimming being my passions, yet I still wasn’t able to escape severe vein disease. By the time I had my third child, it was painful to walk, [and even more] when I tried to continue any physical activities with my kids. The pain was unbearable,” she said.

She described how her legs looked awful, her self-confidence was disappearing, and she couldn’t wear shorts or skirts until a friend told her about D’OXYVA. She did some research and she realized that there was a safe, effective, and innovative alternative way to treat her varicose veins.

“I was a young mom with legs that looked and made me feel as though I was 100. If possible, I didn’t want to undergo any surgical procedures. After going to more than 4 vein centers and having no success using non-invasive procedures, this made me decide to try out D’OXYVA,” Annie said.

At first, she was skeptical, but to her delight, the applications were quick, easy to use, and 100% painless.

“I requested a customized regimen plan; their customer support was so helpful and advised for me to strictly do D’OXYVA therapy once a day by directly spraying the vapor onto to the vein. I couldn’t believe my eyes; after just one 5-minute therapy session, the appearance significantly improved.”

After 4 weeks of D’OXYVA therapy, Annie is back to running better than ever and can even wear shorts without being embarrassed! She’s back on the playing field cheering on her kids, and she’s back to feeling like herself again.

“I finally have my life back and am almost completely pain free. I have such a great appreciation and admiration for everyone behind this amazing product. I have never been treated so personally and kindly by any other company offering [similar] products I have previously tried. I would recommend D’OXYVA to anyone and everyone suffering from varicose veins! The help is there; it may not be as cheap as the OTC remedies, but it’s worth it!”

Posted on by — Leave a comment

Diabetes drug recalled over excess levels of cancer-causing agent

Heads up, consumers: A diabetes drug is facing recall because the medication contains excess levels of a cancer-causing agent, the U.S. Food and Drug Administration (FDA) announced this week.

Marksans Pharma Limited, a pharmaceutical company in India, announced an expanded recalled of its Metformin hydrochloride extended-release tablets, a drug used to help those who suffer from type 2 diabetes to lower their blood glucose levels. The recall, which was initially announced in June, was expanded on Monday to include an additional 76 unexpired lots of the medication.

An example of the recalled medication. (FDA)

“Marksans performed N-Nitrosodimethylamine (NDMA) testing of unexpired identified marketed lots and observed that NDMA content in some lots is exceeding the acceptable Daily Intake Limit (ADI) of 96ng/day, therefore, out of an abundance of caution, an additional 76 lots are being recalled,” the FDA said when announcing the recall. 

NDMA is a “probable human carcinogen,” meaning it’s a substance that can lead to cancer, per the FDA.

“NDMA is a known environmental contaminant found in water and foods, including meats, dairy products and vegetables. Marksans Pharma Limited has not received any reports of adverse events that have been related to this recall,” the FDA said.

The recall impacts metformin tablets between 500 mg and 750 mg. The tablets were sold under the brand name Time-Cap Labs, Inc., according to the announcement.

The following products have been called back:

Metformin Hydrochloride Extended-Release Tablets, USP 500mg:

90 counts: 49483-623-09

100 counts: 49483-623-01

500 counts: 49483-623-50

1000 counts: 49483-623-10

Metformin Hydrochloride Extended-Release Tablets, USP 750mg:

100 counts: 49483-624-01

The 500 mg tablets are debossed with “101” on one side and are plain on the other. The 750 mg tablets, meanwhile, are also debossed with “102” on one side and are plain on the other, per the FDA.

“Consumers taking these recalled product lots of Metformin ER Tablets should continue taking it until a doctor or pharmacist gives them a replacement or a different treatment option. It could be dangerous for patients with type 2 diabetes to stop taking their metformin without first talking to their health care professional,” the FDA warned. The consumer “should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.”

Posted on by — Leave a comment

Scientists just beginning to understand the many health problems caused by COVID-19

CHICAGO – Scientists are only starting to grasp the vast array of health problems caused by the novel coronavirus, some of which may have lingering effects on patients and health systems for years to come, according to doctors and infectious disease experts.

Besides the respiratory issues that leave patients gasping for breath, the virus that causes COVID-19 attacks many organ systems, in some cases causing catastrophic damage.

“We thought this was only a respiratory virus. Turns out, it goes after the pancreas. It goes after the heart. It goes after the liver, the brain, the kidney and other organs. We didn’t appreciate that in the beginning,” said Dr. Eric Topol, a cardiologist and director of the Scripps Research Translational Institute in La Jolla, California.

In addition to respiratory distress, patients with COVID-19 can experience blood clotting disorders that can lead to strokes, and extreme inflammation that attacks multiple organ systems. The virus can also cause neurological complications that range from headache, dizziness and loss of taste or smell to seizures and confusion.

And recovery can be slow, incomplete and costly, with a huge impact on quality of life.

The broad and diverse manifestations of COVID-19 are somewhat unique, said Dr. Sadiya Khan, a cardiologist at Northwestern Medicine in Chicago.

With influenza, people with underlying heart conditions are also at higher risk of complications, Khan said. What is surprising about this virus is the extent of the complications occurring outside the lungs.

Khan believes there will be a huge healthcare expenditure and burden for individuals who have survived COVID-19.

LENGTHY REHAB FOR MANY

Patients who were in the intensive care unit or on a ventilator for weeks will need to spend extensive time in rehab to regain mobility and strength.

“It can take up to seven days for every one day that you’re hospitalized to recover that type of strength,” Khan said. “It’s harder the older you are, and you may never get back to the same level of function.”

While much of the focus has been on the minority of patients who experience severe disease, doctors increasingly are looking to the needs of patients who were not sick enough to require hospitalization, but are still suffering months after first becoming infected.

Studies are just getting underway to understand the long-term effects of infection, Jay Butler, deputy director of infectious diseases at the U.S. Centers for Disease Control and Prevention, told reporters in a telephone briefing on Thursday.

“We hear anecdotal reports of people who have persistent fatigue, shortness of breath,” Butler said. “How long that will last is hard to say.”

While coronavirus symptoms typically resolve in two or three weeks, an estimated 1 in 10 experience prolonged symptoms, Dr. Helen Salisbury of the University of Oxford wrote in the British Medical Journal on Tuesday.

Salisbury said many of her patients have normal chest X-rays and no sign of inflammation, but they are still not back to normal.

“If you previously ran 5k three times a week and now feel breathless after a single flight of stairs, or if you cough incessantly and are too exhausted to return to work, then the fear that you may never regain your previous health is very real,” she wrote.

Dr. Igor Koralnik, chief of neuro-infectious diseases at Northwestern Medicine, reviewed current scientific literature and found about half of patients hospitalized with COVID-19 had neurological complications, such as dizziness, decreased alertness, difficulty concentrating, disorders of smell and taste, seizures, strokes, weakness and muscle pain.

Koralnik, whose findings were published in the Annals of Neurology, has started an outpatient clinic for COVID-19 patients to study whether these neurological problems are temporary or permanent.

Khan sees parallels with HIV, the virus that causes AIDS. Much of the early focus was on deaths.

“In recent years, we’ve been very focused on the cardiovascular complications of HIV survivorship,” Khan said.

Source

https://www.foxbusiness.com/lifestyle/scientists-just-beginning-to-understand-the-many-health-problems-caused-by-covid-19

Posted on by — Leave a comment

Inspiring Story: The Case of C.A., “D’Oxyva is my game changer”

Carol Anne's Inspiring Story

Watch Carol Anne’s brief but amazing video below.

For two years, living has been like trying to survive between a rock and a hard place, as the saying goes. I’ve been on death’s door more than once, from intense chronic hip pain and loss of mobility to oozing leg wounds and infections; surgeons refused to do hip surgery because of my wounds. There were definitely times when I didn’t think I’d make it through.

One day, my best friend, Mo, called me up very excited and told me to check out DOxyva.com. She said there was evidence online that the application could assist with wound healing. I was living a nightmare of constant pain, stress, and little hope, struggling just to get myself through the next 24 hours. I called D’Oxyva and spoke with John, grilling him with what felt like a thousand questions. I just did not want to get my hopes up just to crash with disappointment. I waited for a sign. Each time my thoughts circled back to D’Oxyva, I started to hear the words “game changer” in my head. When a friend called to check in on me and I described the concept to her, she said outright, “CA, I think this could be your game changer.” My eyes filled with tears.

I ordered a full kit with five boxes and didn’t look back.

How my wound looks like before D’OXYVA (Warning! The following image may be disturbing, viewer discretion is advised.)

I have been so very sick while waiting almost five years for a much-needed hip replacement surgery! I developed a non-diabetic lower leg wound (from a scratch), becoming wheelchair bound and unable to walk. After over 17 months suffering from severe wound complications, neuropathy and extreme lymphedema (from a drug allergy), I am absolutely thrilled to embrace the full force of my healing journey with twice-daily D’Oxyva application! After a few short weeks using D’Oxyva, not only has the swelling in my legs subsided, the skin around my wound has completely healed, and the wound itself continues to shrink from over 1.5 inches to less than ¼ of an inch in depth (see progress photos). I continue to drop inches from swelling throughout my body, and my physical strength improves every single day. Before I began D’Oxyva, I could barely stand for 5 minutes; now, I can manage 30-40 minutes! I sleep more deeply, my anxiety is disappearing and my stamina grows each day. My nurses, health care aides and doctors have observed the tremendous changes in me with excitement, anticipation and support from week to week.


After few short weeks of using D’OXYVA, here’s how my wound looks like now (Warning! The following image may be disturbing, viewer discretion is advised.)

I still have much healing to get through; however, I know that I would not be living this daily miracle if not for MY D’OXYVA! It Is my game changer!

Follow this blog if you like; as my D’OXYVA journey continues, I will be sharing my progress, challenges, fears and joys.

Thanks for taking the time to read this. I hope you find YOUR game changer!  

My best to you,

C.A.